• Users Online: 699
  • Print this page
  • Email this page
Year : 2001  |  Volume : 6  |  Issue : 1  |  Page : 32-36

Isradipine decreases arterial thrombogenicity in rabbits

Wilhelm Auerswald Atherosclerosis Research Group (A.S.F) Vienna, Department of Nuclear Medcine, University of Vienna, Austria

Correspondence Address:
J C Igweh
College of Medicine, University of Nigeria, Enugu Campus
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Aim: To examine the effect of isradipine, a member of the dihydrophyridine family of calcium antagonists, on aortic and iliac wall thrombogenicity Materials and Methods: After one week of dosing, the abdominal aorta and iliac artery endothelium was abraded using fogarthy catheter. Aortic and iliac thrombogenicity was assessed, after perfusion in situ, by morphological quantification of platelet deposition using the Baumgartner technique as well as by counting the radioactivity after radiolabeling of autologous platelets with 111 in-oxine. One group of animals (n=8) were dosed for one week with isradipine 0.3 mg/kg. A second group of animals received 50mg acetylsalicylic acid (A.S.A) daily in addition, while a third group received the vehicle only. Finally a fourth group of animals (n=8) were treated with aspirin only. Results: The percentage of the denuded surface covered with contact (unspread) platelets decreased significantly (*p<0.01). From 14.7 ± 2.0 to 9.3 ± 2.1* (6.2 ± 0.8 to 3.7 ± 0.4). The amount of contact and spread of platelets was diminished from 84.9 ± 5.6 to 71.4 ± 4.4* (91.8 ± 5.3 to 75.2 ± 4.6*). Platelet thrombi decreased from 7.4 ± 0.9 to 4.6 ± 1.4* (9.4 ± 1.9 to 5.2 ± 0.7*) in the aorta and iliac artery, respectively. 111 in-oxine Platelet deposition decreased by 39.9 and 41.9%. Concomitant A.S.A-therapy not only abolished the effect of isradipine, but also ehanced thrombogenicity probably as a result of almost complete blockade of vascular PG12-production. A.S.A. alone induced an even more thrombogenic action. Conclusion: The result from both methods show that isradipine exerts significant benefits on vascular thrombogenicity most likely via enhanced PG12 formation leading to improved platelet vessel-wall interaction. This benefit can be absolished and thrombogenicity even increased by cyclo-oxygenase blockade.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal